Spyre Therapeutics Inc.

NASDAQ: SYRE
Share price (12/15/25): $33.34
Market cap (12/15/25): $2.587 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3 2024 – amended

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Updated info for already-effective prospectus

Registration of securities for employees

Ownership Filter

Fairmount Funds Management LLC

Burrows Scott L

News Filter

Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Material Definitive Agreement, Financial Statements or Exhibits

Earnings Release or Operating Update

Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Announces Positive Interim Phase 1 Results for Two Next- Generation TL1A Antibody Programs, and Provides Clinical Development Updates Expected to Deliver 9 Phase 2 Readouts

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Notice of effectiveness